30 Jun 2022
(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma
Newswise — A group of researchers including Antonio Giordano, M.D., Ph.D., Director and...
28 Jun 2022
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
Original Newswise post There is a growing awareness that the...
20 Jun 2022
Sbarro Health Research Organization (SHRO) Arrives in Campania
“If I have seen further it is by standing on...
15 Aug 2021
Deeper Understanding of Malignant Mesothelioma Reveals New Novel Targets to Investigate
Progranulin is a growth factor in cellular activity that is...
15 Aug 2021
Researchers Call for More Transparency from Russia’s Sputnik COVID Vaccine
“It is not a problem connected to “the Sputnik V”...
15 Aug 2021
SHRO’s Giordano Meets with Speaker Pelosi at Italian Embassy in Washington
Newswise — WASHINGTON, D.C. May 19, 2021—At the prestigious setting...
15 Aug 2021
Inflammation and Procalcitonin Predict Success, or Not, of Lung Cancer Treatment
In patients with non-small cell Lung Cancer (NSCLC), the presence...
15 Aug 2021
The Medicine in Eye Drops Needs a Disguise to Sneak Past Your Tears
Scientists use engineered protein coating that binds to receptors on...